Temat: Flawed ivermectin preprint highlights challenges of COVID drug research

The examinee's withdrawal from a preprint platform offers a blow to the anti-parasite drug’s probabilities as a COVID treatment, researchers say.
Throughout the pandemic, the anti-parasite drug ivermectin has attracted plenty interest, especially in Latin America, as a capacity way to treat COVID-19. But scientists say that latest, shocking revelations of big flaws within the information of a preprint study reporting that the medication greatly reduces COVID-19 deaths dampens ivermectin promise — and highlights the challenges of investigating drug efficacy at some point of a virus. https://www.oncohiv.com/iverheal-ivermectin-3mg to buy ivermectin
We need a standard drug research roadmap, and international recognition. Currently, COVID has been controlled quite effectively from vaccines of other famous countries https://elasticman.co.